https://www.selleckchem.com/pr....oducts/marimastat.ht
03), whereas the prognostic value of ADAM12 was not evident in patients not treated with nab-PTX (P=0.12). A negative prognostic value of high ADAM12 expression was observed in patients with PDAC treated with surgical resection, which was enhanced in patients treated with NAC, including nab-PTX. These results suggested that ADAM12 expression can predict nab-PTX chemosensitivity in PDAC and reflect PDAC progression. A negative prognostic value of high ADAM12 expression was observed in patients with PDAC treated with surgical resection
Like
Comment
Share
